On the public citation graph

The safety and efficacy of high‐dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial

0 signed · 203 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/cncr.21811openalex-snapshot
Radiation therapy for hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/cncr.21979openalex-snapshot
Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy
inferredcites →https://doi.org/10.1002/cncr.22039openalex-snapshot
Proton beam therapy for hepatocellular carcinoma with limited treatment options
inferredcites →https://doi.org/10.1007/978-1-4612-4380-9_25openalex-snapshot
Nonparametric Estimation from Incomplete Observations
inferredcites →https://doi.org/10.1016/0002-9610(92)90039-topenalex-snapshot
Primary treatment of hepatocellular carcinoma by arterial chemoembolization
inferredcites →https://doi.org/10.1016/0168-8278(90)90110-dopenalex-snapshot
A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/0360-3016(91)90564-kopenalex-snapshot
The use of 3-D dose volume analysis to predict radiation hepatitis
inferredcites →https://doi.org/10.1016/0360-3016(92)90651-wopenalex-snapshot
The use of 3-D dose volume analysis to predict radiation hepatitis
inferredcites →https://doi.org/10.1016/0360-3016(94)00418-kopenalex-snapshot
Hepatic toxicity resulting from cancer treatment
inferredcites →https://doi.org/10.1016/j.ijrobp.2008.04.035openalex-snapshot
Radiotherapeutic Parameters Predictive of Liver Complications Induced by Liver Tumor Radiotherapy
inferredcites →https://doi.org/10.1016/s0140-6736(03)14964-1openalex-snapshot
Hepatocellular carcinoma
inferredcites →https://doi.org/10.1053/j.gastro.2003.12.049openalex-snapshot
Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance☆
inferredcites →https://doi.org/10.1053/j.gastro.2004.09.033openalex-snapshot
High-Dose proton beam radiotherapy of hepatocellular carcinoma: Preliminary results of a phase II trial
inferredcites →https://doi.org/10.1053/jhep.2002.33156openalex-snapshot
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
inferredcites →https://doi.org/10.1056/nejm199603143341104openalex-snapshot
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
inferredcites →https://doi.org/10.1056/nejm199903113401001openalex-snapshot
Rising Incidence of Hepatocellular Carcinoma in the United States
inferredcites →https://doi.org/10.1111/j.2517-6161.1972.tb00899.xopenalex-snapshot
Regression Models and Life-Tables
inferredcites →https://doi.org/10.1118/1.597435openalex-snapshot
A review of proton beam radiation therapy
inferredcites →https://doi.org/10.1158/1078-0432.ccr-04-1350openalex-snapshot
Proton Beam Therapy for Hepatocellular Carcinoma: A Retrospective Review of 162 Patients
inferredcites →https://doi.org/10.1200/jco.2005.00.620openalex-snapshot
Phase II Study of Radiotherapy Employing Proton Beam for Hepatocellular Carcinoma
inferredcites →https://doi.org/10.3322/caac.20107openalex-snapshot
Global cancer statistics
inferredcites →https://doi.org/10.3322/canjclin.55.2.74openalex-snapshot
Global Cancer Statistics, 2002

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.5037835openalex-extracted
Simultaneous Integrated Boost and Protection Proton Beam Therapy Approach for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.2139/ssrn.5237031openalex-extracted
Simultaneous Integrated Boost and Protection Proton Beam Therapy Approach for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1002/14651858.cd011314.pub2openalex-snapshot
External beam radiotherapy for unresectable hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/9781119707530.ch19openalex-snapshot
Hepatobiliary Cancers
inferred← citeshttps://doi.org/10.1002/cncr.30816openalex-snapshot
Progressive hypofractionated carbon‐ion radiotherapy for hepatocellular carcinoma: Combined analyses of 2 prospective trials
inferred← citeshttps://doi.org/10.1002/cncr.31334openalex-snapshot
The role of external beam radiotherapy in the treatment of hepatocellular cancer
inferred← citeshttps://doi.org/10.1002/cncr.34965openalex-snapshot
Proton beam radiotherapy versus transarterial chemoembolization for hepatocellular carcinoma: Results of a randomized clinical trial
inferred← citeshttps://doi.org/10.1002/jgf2.19openalex-snapshot
Radiotherapy for liver cancer
inferred← citeshttps://doi.org/10.1002/jso.25495openalex-snapshot
Validation of combination treatment with surgical spacer placement and subsequent particle radiotherapy for unresectable hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/lt.23714openalex-snapshot
Down-staging of hepatocellular carcinoma via external-beam radiotherapy with subsequent liver transplantation: A case report
inferred← citeshttps://doi.org/10.1007/174_2019_216openalex-snapshot
Controversies in Radiotherapy for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1007/978-1-4939-0870-7_7openalex-snapshot
Hepatitis B Virus: Epidemiology and Clinical Features of Related Cancer
inferred← citeshttps://doi.org/10.1007/978-3-030-16924-4_20openalex-snapshot
Charged Particle Stereotactic Body Radiation Therapy
inferred← citeshttps://doi.org/10.1007/978-3-030-21540-8_10openalex-snapshot
Precision Locoregional Therapies for Hepatocellular Carcinoma: Percutaneous Ablation and Radiotherapy
inferred← citeshttps://doi.org/10.1007/978-3-030-24490-3_13openalex-snapshot
The Management of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1007/978-3-031-67743-4_19openalex-snapshot
Charged Particle Stereotactic Body Radiation Therapy
inferred← citeshttps://doi.org/10.1007/978-3-319-54531-8_10openalex-snapshot
Particle Radiation Therapy for Liver Tumors: Simulation and Treatment Planning
inferred← citeshttps://doi.org/10.1007/978-3-319-54531-8_14openalex-snapshot
Radiation Therapy for Hepatocellular Carcinoma: Clinical Data
inferred← citeshttps://doi.org/10.1007/978-3-319-64900-9_7openalex-snapshot
Proton Beam Therapy for Hepatic Malignancies
inferred← citeshttps://doi.org/10.1007/978-3-319-91977-5_6openalex-snapshot
Role of Radiation Therapy in Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1007/978-3-540-88305-0_23openalex-snapshot
Hepatobiliäre Tumoren und Lebermetastasen
inferred← citeshttps://doi.org/10.1007/978-981-16-1815-4_6openalex-snapshot
Technological Advances in Radiotherapy
inferred← citeshttps://doi.org/10.1007/978-981-16-1815-4_9openalex-snapshot
Particle Beam Radiotherapy
inferred← citeshttps://doi.org/10.1007/978-981-19-0063-1_18openalex-snapshot
Use of Radiotherapy Alone and in Combination with Other Therapies for Hepatocellular Carcinoma: Rationale and Future Directions
inferred← citeshttps://doi.org/10.1007/s00066-016-0957-0openalex-snapshot
Radioablation of liver malignancies with interstitial high-dose-rate brachytherapy
inferred← citeshttps://doi.org/10.1007/s00595-019-01888-5openalex-snapshot
A comparison of the outcomes between surgical resection and proton beam therapy for single primary hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s00761-018-0439-3openalex-snapshot
Strahlentherapie bei hepatozellulärem Karzinom
inferred← citeshttps://doi.org/10.1007/s10147-012-0390-zopenalex-snapshot
Clinical evidence of particle beam therapy (proton)
inferred← citeshttps://doi.org/10.1007/s10147-017-1190-2openalex-snapshot
A systematic review of publications on charged particle therapy for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s10620-019-05539-0openalex-snapshot
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current State and Future Opportunities
inferred← citeshttps://doi.org/10.1007/s11010-014-2314-xopenalex-snapshot
Ursolic acid inhibited growth of hepatocellular carcinoma HepG2 cells through AMPKα-mediated reduction of DNA methyltransferase 1
inferred← citeshttps://doi.org/10.1007/s11604-018-0757-9openalex-snapshot
Normal liver tissue change after proton beam therapy
inferred← citeshttps://doi.org/10.1007/s11670-012-0276-7openalex-snapshot
Proton therapy for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s11888-021-00472-9openalex-snapshot
The Role of Ablative Radiotherapy to Liver Oligometastases from Colorectal Cancer
inferred← citeshttps://doi.org/10.1007/s11912-013-0373-xopenalex-snapshot
Nonsurgical Treatment for Localized Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1007/s11912-016-0499-8openalex-snapshot
Particle Radiation Therapy for Gastrointestinal Cancers
inferred← citeshttps://doi.org/10.1007/s12029-012-9387-0openalex-snapshot
Unresectable Hepatocellular Carcinoma Due to Portal Venous Thrombosis: Focal Stereotactic Body Radiation Therapy Can Promote Resectability
inferred← citeshttps://doi.org/10.1007/s12328-025-02266-0openalex-snapshot
Successful treatment of β-catenin-positive, immune checkpoint inhibitor-resistant tumor in a case of multicentric hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s13277-015-3144-5openalex-snapshot
The comparison of outcomes between hypofractionated and conventional 3D-CRT regimens used in combination with TACE as first-line treatment of advanced hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/b978-0-323-24098-7.00049-6openalex-snapshot
Hepatobiliary Cancer
inferred← citeshttps://doi.org/10.1016/b978-0-323-73349-6.00019-4openalex-snapshot
Gastrointestinal
inferred← citeshttps://doi.org/10.1016/j.adro.2021.100675openalex-snapshot
Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience
inferred← citeshttps://doi.org/10.1016/j.clon.2014.05.016openalex-snapshot
The Role of Radiotherapy and Chemoradiation in the Management of Primary Liver Tumours
inferred← citeshttps://doi.org/10.1016/j.ctro.2025.101008openalex-snapshot
Simultaneous integrated boost and protection proton beam therapy approach for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.ejca.2026.116593openalex-snapshot
Tailored proton beam therapy for hepatocellular carcinoma: Addressing unmet needs through a multidisciplinary approach
inferred← citeshttps://doi.org/10.1016/j.hoc.2019.08.016openalex-snapshot
Novel Radiotherapy Technologies in the Treatment of Gastrointestinal Malignancies
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2012.08.043openalex-snapshot
Hepatocellular Carcinoma Radiation Therapy: Review of Evidence and Future Opportunities
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2014.03.041openalex-snapshot
Interobserver Variability in Target Definition for Hepatocellular Carcinoma With and Without Portal Vein Thrombus: Radiation Therapy Oncology Group Consensus Guidelines
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2016.02.027openalex-snapshot
Randomized Clinical Trial Comparing Proton Beam Radiation Therapy with Transarterial Chemoembolization for Hepatocellular Carcinoma: Results of an Interim Analysis
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2016.09.021openalex-snapshot
Pancreatic, Rectal, and Liver Cancers: Out With the Old, In With the New
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2018.08.061openalex-snapshot
The Case for Proton Beam Therapy
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2019.01.076openalex-snapshot
Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall Survival
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2019.02.032openalex-snapshot
Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2023.09.047openalex-snapshot
Proton Beam Therapy for Hepatocellular Carcinoma: Multicenter Prospective Registry Study in Japan
inferred← citeshttps://doi.org/10.1016/j.jceh.2014.05.002openalex-snapshot
Role of External Beam Radiation Therapy in Management of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1016/j.jhep.2020.09.026openalex-snapshot
Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial
inferred← citeshttps://doi.org/10.1016/j.jhepr.2022.100498openalex-snapshot
Stereotactic body radiation therapy for hepatocellular carcinoma: From infancy to ongoing maturity
inferred← citeshttps://doi.org/10.1016/j.prro.2015.08.005openalex-snapshot
Impact of intravenous contrast enhancement phase on target definition for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (IHC): Observations from patients enrolled on a prospective phase 2 trial
inferred← citeshttps://doi.org/10.1016/j.prro.2018.04.012openalex-snapshot
Liver reirradiation for patients with hepatocellular carcinoma and liver metastasis
inferred← citeshttps://doi.org/10.1016/j.prro.2019.09.012openalex-snapshot
Impact of Proton Beam Irradiation of an Anatomic Subsegment of the Liver for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1016/j.prro.2019.12.010openalex-snapshot
Palliative External Beam Radiation Therapy for Hepatocellular Carcinoma With Right Atrial Tumor Thrombus
inferred← citeshttps://doi.org/10.1016/j.prro.2021.09.004openalex-snapshot
External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline
inferred← citeshttps://doi.org/10.1016/j.radonc.2014.02.001openalex-snapshot
Is there a role for proton therapy in the treatment of hepatocellular carcinoma? A systematic review
inferred← citeshttps://doi.org/10.1016/j.radonc.2014.11.033openalex-snapshot
Charged particle therapy versus photon therapy for patients with hepatocellular carcinoma: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.radonc.2018.10.009openalex-snapshot
A feasibility study of high-dose hypofractionated carbon ion radiation therapy using four fractions for localized hepatocellular carcinoma measuring 3 cm or larger
inferred← citeshttps://doi.org/10.1016/j.radonc.2018.10.041openalex-snapshot
Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.radonc.2018.12.012openalex-snapshot
Patient specific outcomes of charged particle therapy for hepatocellular carcinoma – A systematic review and quantitative analysis
inferred← citeshttps://doi.org/10.1016/j.radonc.2019.01.028openalex-snapshot
Effect of setup and inter-fraction anatomical changes on the accumulated dose in CT-guided breath-hold intensity modulated proton therapy of liver malignancies
inferred← citeshttps://doi.org/10.1016/j.radonc.2020.09.035openalex-snapshot
Clinical implementation of pencil beam scanning proton therapy for liver cancer with forced deep expiration breath hold
inferred← citeshttps://doi.org/10.1016/j.radonc.2022.02.031openalex-snapshot
Magnetic resonance imaging (MRI) guided proton therapy: A review of the clinical challenges, potential benefits and pathway to implementation
inferred← citeshttps://doi.org/10.1016/j.radonc.2022.09.003openalex-snapshot
A phase II trial of hypofractionated high-dose proton beam therapy for unresectable liver metastases
inferred← citeshttps://doi.org/10.1016/j.semradonc.2017.11.006openalex-snapshot
Will There Be a Clinically Significant Role for Protons in Patients With Gastrointestinal Malignancies?
inferred← citeshttps://doi.org/10.1016/j.semradonc.2018.06.005openalex-snapshot
Radiotherapy for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1016/j.semradonc.2018.06.008openalex-snapshot
Proton Beam Therapy and Carbon Ion Radiotherapy for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1016/j.soc.2013.10.007openalex-snapshot
An Emerging Role for Radiation Therapy in the Treatment of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
inferred← citeshttps://doi.org/10.1016/j.soc.2023.02.002openalex-snapshot
Advances in Radiation Therapy for Primary Liver Cancer
inferred← citeshttps://doi.org/10.1016/j.suc.2013.08.008openalex-snapshot
Management of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1016/j.surg.2017.08.006openalex-snapshot
Particle radiotherapy, a novel external radiation therapy, versus liver resection for hepatocellular carcinoma accompanied with inferior vena cava tumor thrombus: A matched-pair analysis
inferred← citeshttps://doi.org/10.1016/j.transproceed.2015.02.011openalex-snapshot
Salvage Living-Donor Liver Transplantation for Liver Failure Following Definitive Radiation Therapy for Recurrent Hepatocellular Carcinoma: A Case Report
inferred← citeshttps://doi.org/10.1016/j.zemedi.2017.07.005openalex-snapshot
Experimental validation of a 4D dose calculation routine for pencil beam scanning proton therapy
inferred← citeshttps://doi.org/10.1016/j.zemedi.2020.08.001openalex-snapshot
Mitigation of motion effects in pencil-beam scanning – Impact of repainting on 4D robustly optimized proton treatment plans for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/s0168-8278(13)60260-3openalex-snapshot
258 HYPOFRACTIONATED CARBON ION THERAPY DELIVERED WITH SCANNED ION BEAMS FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA – FEASIBILITY AND CLINICAL RESPONSE
inferred← citeshttps://doi.org/10.1021/acsami.5c05525openalex-snapshot
Micro-Nano Convergence-Driven Radiotheranostic Revolution in Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1055/s-0033-1355841openalex-snapshot
Diagnostik und Therapie des hepatozellulären Karzinoms
inferred← citeshttps://doi.org/10.1055/s-0038-1676098openalex-snapshot
Radiation Therapy in HCC: What Data Exist and What Data Do We Need to Incorporate into Guidelines?
inferred← citeshttps://doi.org/10.1055/s-0039-1700515openalex-snapshot
Pre-Liver Transplantation Evaluation and Listing
inferred← citeshttps://doi.org/10.1080/14737140.2017.1368392openalex-snapshot
Proton beam therapy for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1088/0034-4885/79/9/096702openalex-snapshot
Nuclear physics in particle therapy: a review
inferred← citeshttps://doi.org/10.1088/1361-6560/aaecfcopenalex-snapshot
Motion effects in proton treatments of hepatocellular carcinoma—4D robustly optimised pencil beam scanning plans versus double scattering plans
inferred← citeshttps://doi.org/10.1088/1742-6596/1154/1/012021openalex-snapshot
4D robust optimization in pencil beam scanning proton therapy for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1093/jrr/rraa098openalex-snapshot
Capacity of proton beams in preserving normal liver tissue during proton beam therapy for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1093/jrr/rry056openalex-snapshot
A validated proton beam therapy patch-field protocol for effective treatment of large hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1093/oncolo/oyae048openalex-snapshot
Concurrent Atezolizumab Plus Bevacizumab and High-Dose External Beam Radiotherapy for Highly Advanced Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1097/ppo.0000000000000078openalex-snapshot
Comparing the Use of Protons and Carbon Ions for Treatment
inferred← citeshttps://doi.org/10.1097/ppo.0000000000000082openalex-snapshot
The Use of Proton Therapy in the Treatment of Gastrointestinal Cancers
inferred← citeshttps://doi.org/10.1097/ppo.0000000000000819openalex-snapshot
Hypofractionated Particle Therapy: A Review of Clinical Data and Implications
inferred← citeshttps://doi.org/10.1111/1754-9485.13021openalex-snapshot
Particle therapy tumour outcomes: An updated systematic review
inferred← citeshttps://doi.org/10.1111/cas.13145openalex-snapshot
Long‐term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1111/liv.13969openalex-snapshot
Short‐course carbon‐ion radiotherapy for hepatocellular carcinoma: A multi‐institutional retrospective study
inferred← citeshttps://doi.org/10.1142/9789814618991_0023openalex-snapshot
Proton Therapy: A New Dawn for Gastrointestinal Cancer Treatment
inferred← citeshttps://doi.org/10.1159/000367764openalex-snapshot
Liver-Directed Radiotherapy for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1159/000367767openalex-snapshot
How to Improve Therapeutic Ratio in Radiotherapy of HCC
inferred← citeshttps://doi.org/10.1159/000487311openalex-snapshot
Effectiveness of Particle Radiotherapy in Various Stages of Hepatocellular Carcinoma: A Pilot Study
inferred← citeshttps://doi.org/10.1177/0300891620937809openalex-snapshot
Clinical results of active scanning proton therapy for primary liver tumors
inferred← citeshttps://doi.org/10.1177/1073274817729242openalex-snapshot
Role and Future Directions of External Beam Radiotherapy for Primary Liver Cancer
inferred← citeshttps://doi.org/10.1177/1533033818790217openalex-snapshot
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and Controversies
inferred← citeshttps://doi.org/10.1177/15330338231206335openalex-snapshot
Proton Beam Therapy and Photon-Based Magnetic Resonance Image-Guided Radiation Therapy: The Next Frontiers of Radiation Therapy for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1186/1748-717x-8-239openalex-snapshot
A phase I study on combined therapy with proton-beam radiotherapy and in situ tumor vaccination for locally advanced recurrent hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1186/1748-717x-8-48openalex-snapshot
What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy
inferred← citeshttps://doi.org/10.1186/1748-717x-8-59openalex-snapshot
Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma – feasibility and clinical response
inferred← citeshttps://doi.org/10.1186/s12880-017-0202-zopenalex-snapshot
Registration error of the liver CT using deformable image registration of MIM Maestro and Velocity AI
inferred← citeshttps://doi.org/10.1186/s13014-016-0745-0openalex-snapshot
External beam radiotherapy for unresectable hepatocellular carcinoma, an international multicenter phase I trial, SAKK 77/07 and SASL 26
inferred← citeshttps://doi.org/10.1186/s13014-020-01703-3openalex-snapshot
Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group
inferred← citeshttps://doi.org/10.1186/s13046-016-0330-2openalex-snapshot
Inter-regulation of IGFBP1 and FOXO3a unveils novel mechanism in ursolic acid-inhibited growth of hepatocellular carcinoma cells
inferred← citeshttps://doi.org/10.1200/jco.2015.64.2710openalex-snapshot
Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
inferred← citeshttps://doi.org/10.1259/bjr.20190226openalex-snapshot
Proton beam therapy for tumors of the upper abdomen
inferred← citeshttps://doi.org/10.12965/jer.2550482.241openalex-snapshot
Spectrum of therapeutic options in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.14694/edbook_am.2014.34.e150openalex-snapshot
Radiation Oncology Approaches in Liver Malignancies
inferred← citeshttps://doi.org/10.1515/oncologie-2025-0265openalex-snapshot
Current application status of proton beam therapy for gastrointestinal tumors
inferred← citeshttps://doi.org/10.1634/theoncologist.2014-0097openalex-snapshot
Radiation Therapy for Liver Tumors: Ready for Inclusion in Guidelines?
inferred← citeshttps://doi.org/10.17169/refubium-6376openalex-snapshot
Vergleichender Zytotoxizitätsnachweis der Immunsuppressiva Sirolimus und Mycophenolatmofetil auf die humanen hepatozellulären Karzinom-Zelllinien HEP3B und SKHEP1 in vitro
inferred← citeshttps://doi.org/10.17998/jlc.2022.11.07openalex-snapshot
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.18528/ijgii210043openalex-snapshot
Current role of proton beam therapy in patients with hepatocellular carcinoma
inferred← citeshttps://doi.org/10.20517/2394-5079.2018.84openalex-snapshot
Hypofractionated ablative radiation therapy for hepatocellular carcinoma: practical considerations and review of the literature
inferred← citeshttps://doi.org/10.20517/2394-5079.2018.95openalex-snapshot
Minimally invasive therapies for hepatocellular carcinoma: narrowing the gaps
inferred← citeshttps://doi.org/10.20944/preprints202407.2257.v1openalex-snapshot
Combining Immunotherapy with Stereotactic Body Radiation Therapy (SBRT) in Unresectable Hepatocellular Carcinoma-The Rationale and Review of Literature
inferred← citeshttps://doi.org/10.21037/789openalex-snapshot
Stereotactic body proton therapy for liver metastases
inferred← citeshttps://doi.org/10.21037/apm-22-965openalex-snapshot
Palliative radiotherapy for hepatic tumors: a narrative review of indications and recommendations
inferred← citeshttps://doi.org/10.21037/jgo-20-424openalex-snapshot
Proton stereotactic body radiation therapy for liver metastases—results of 5-year experience for 81 hepatic lesions
inferred← citeshttps://doi.org/10.21037/jgo-21-116openalex-snapshot
Ablative radiation therapy for hepatocellular carcinoma is associated with reduced treatment- and tumor-related liver failure and improved survival
inferred← citeshttps://doi.org/10.21037/jgo-23-757openalex-snapshot
Particle therapy in gastrointestinal cancer—a narrative review
inferred← citeshttps://doi.org/10.21037/jgo.2016.05.06openalex-snapshot
Clinical outcomes and toxicities of proton radiotherapy for gastrointestinal neoplasms: a systematic review
inferred← citeshttps://doi.org/10.21037/jgo.2016.08.02openalex-snapshot
Radiation therapy for hepatobiliary malignancies
inferred← citeshttps://doi.org/10.21037/jgo.2017.11.07openalex-snapshot
Proton beam therapy for gastrointestinal cancers: past, present, and future
inferred← citeshttps://doi.org/10.21037/jgo.2019.08.03openalex-snapshot
Proton beam therapy versus stereotactic body radiotherapy for hepatocellular carcinoma: practice patterns, outcomes, and the effect of biologically effective dose escalation
inferred← citeshttps://doi.org/10.21037/tcr.2018.11.01openalex-snapshot
Significance of indocyanine green test in radiotherapy for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.2147/jhc.s284403openalex-snapshot
Current Understanding of Ablative Radiation Therapy in Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.2147/jhc.s48763openalex-snapshot
Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma
inferred← citeshttps://doi.org/10.2169/naika.103.116openalex-snapshot
7. Radiotherapy of Liver Cancer
inferred← citeshttps://doi.org/10.2217/fon.14.167openalex-snapshot
Stereotactic Body Radiotherapy: An Effective Local Treatment Modality for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.2217/hep.15.7openalex-snapshot
Radiotherapy for liver tumors
inferred← citeshttps://doi.org/10.2957/kanzo.65.204openalex-snapshot
Current Status and Future Prospects of Particle Therapy for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3109/0284186x.2011.590526openalex-snapshot
Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumours
inferred← citeshttps://doi.org/10.3109/0284186x.2012.718094openalex-snapshot
Dose-volume histogram analysis for risk factors of radiation-induced rib fracture after hypofractionated proton beam therapy for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.3109/0284186x.2015.1009637openalex-snapshot
Normal liver sparing by proton beam therapy for hepatocellular carcinoma: Comparison with helical intensity modulated radiotherapy and volumetric modulated arc therapy
inferred← citeshttps://doi.org/10.3348/kjr.2015.16.3.465openalex-snapshot
2014 Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3348/kjr.2019.0140openalex-snapshot
2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3348/kjr.2022.0822openalex-snapshot
2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3350/cmh.2017.0073openalex-snapshot
Strategic application of radiotherapy for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.3350/cmh.2022.0294openalex-snapshot
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.33582/2637-4501/1005openalex-snapshot
Development of radiotherapy for liver cancer
inferred← citeshttps://doi.org/10.33590/emjhepatol/10311937openalex-snapshot
Nonsurgical Treatment for Localised Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3389/fonc.2015.00302openalex-snapshot
The Role of Hypofractionated Radiation Therapy with Photons, Protons, and Heavy Ions for Treating Extracranial Lesions
inferred← citeshttps://doi.org/10.3389/fonc.2019.00345openalex-snapshot
Rethinking the Role of Radiation Therapy in the Treatment of Unresectable Hepatocellular Carcinoma: A Data Driven Treatment Algorithm for Optimizing Outcomes
inferred← citeshttps://doi.org/10.3389/fonc.2020.00542openalex-snapshot
Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3389/fonc.2022.959552openalex-snapshot
Proton therapy in the treatment of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.3390/cancers11020230openalex-snapshot
Does Risk-Adapted Proton Beam Therapy Have a Role as a Complementary or Alternative Therapeutic Option for Hepatocellular Carcinoma?
inferred← citeshttps://doi.org/10.3390/cancers12071840openalex-snapshot
Transitions of Liver and Biliary Enzymes during Proton Beam Therapy for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3390/cancers14092271openalex-snapshot
The Role of Hypofractionation in Proton Therapy
inferred← citeshttps://doi.org/10.3390/cancers14122900openalex-snapshot
Proton Therapy in the Management of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3390/cancers14184445openalex-snapshot
Proton Beam Therapy for Treatment-Naïve Hepatocellular Carcinoma and Prognostic Significance of Albumin-Bilirubin (ALBI) Grade
inferred← citeshttps://doi.org/10.3390/cancers14235842openalex-snapshot
Long-Term Results of Proton Therapy for Hepatocellular Carcinoma Using Four-Dimensional Computed Tomography Planning without Fiducial Markers
inferred← citeshttps://doi.org/10.3390/cancers17142369openalex-snapshot
NRG Oncology Liver Proton SBRT and Hypofractionated Radiation Therapy: Current Treatment Technical Assessment and Practice Patterns
inferred← citeshttps://doi.org/10.3390/cancers17172849openalex-snapshot
Proton Beam Therapy Provides Longer Survival and Preserves Muscle Mass in Hepatocellular Carcinoma Compared to TACE+RFA
inferred← citeshttps://doi.org/10.3390/curroncol30040296openalex-snapshot
Longer Survival and Preserved Liver Function after Proton Beam Therapy for Patients with Unresectable Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3747/co.23.3394openalex-snapshot
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2016
inferred← citeshttps://doi.org/10.3748/wjg.v21.i1.94openalex-snapshot
Radiation therapy has been shown to be adaptable for various stages of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.3748/wjg.v21.i13.3826openalex-snapshot
Current management of hepatocellular carcinoma: An Eastern perspective
inferred← citeshttps://doi.org/10.3748/wjg.v22.i30.6851openalex-snapshot
Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis
inferred← citeshttps://doi.org/10.3748/wjg.v22.i32.7311openalex-snapshot
Technical advances in external radiotherapy for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.3748/wjg.v24.i28.3090openalex-snapshot
Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives
inferred← citeshttps://doi.org/10.3892/mco.2021.2234openalex-snapshot
Recurrent cholangiocarcinoma with long‑term survival by multimodal treatment: A case report
inferred← citeshttps://doi.org/10.4103/2319-4170.153211openalex-snapshot
What are the potential benefits of using proton therapy in Taiwanese cancer patients?
inferred← citeshttps://doi.org/10.4143/crt.2021.409openalex-snapshot
Patterns of Proton Beam Therapy Use in Clinical Practice between 2007 and 2019 in Korea
inferred← citeshttps://doi.org/10.4236/ijmpcero.2015.42013openalex-snapshot
Proton Therapy Results in the Treatment of Hepatocellular Carcinoma According to the Barcelona-Clinic Liver Cancer (BCLC) Staging System
inferred← citeshttps://doi.org/10.4251/wjgo.v11.i8.579openalex-snapshot
Hypofractionated particle beam therapy for hepatocellular carcinoma–a brief review of clinical effectiveness
inferred← citeshttps://doi.org/10.4254/wjh.v7.i1.101openalex-snapshot
Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review
inferred← citeshttps://doi.org/10.4254/wjh.v7.i11.1460openalex-snapshot
Multidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience
inferred← citeshttps://doi.org/10.5009/gnl14460openalex-snapshot
2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.5009/gnl19024openalex-snapshot
2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.9738/intsurg-d-13-00188.1openalex-snapshot
Effectiveness of Proton Beam Therapy on Liver Metastases of Esophageal Cancer: Report of a Case
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.